Login

Ownership

13F as of Q2 2026 · 103.3M shares outstanding

Who owns Day One Biopharmaceuticals, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 1 holders own 0.0%
IFP Advisors, Inc 0.0%
Institutional ownership
0.0%
-84.1 pts vs last qtr
Institutional holders
1
-207 vs last qtr
Net shares bought
−86.9M
by institutions in Q2 2026
New / sold out
0 / 207
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • BlackRock, Inc. SOLD OUT −7.0M
  • Glazer Capital, LLC SOLD OUT −4.7M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$391K
4 notices from 4 people
Shares covered
33.7K
0.03% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$195.7K$391.3KDecJanFeb 2026: $391.3K without a planFebMarAprMayJunJulAugSepOctNov
Largest proposed sellers
  • Jeremy Bender Officer $179K
  • Adam Dubow Officer $74.2K

Sign up to see all 4.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+1766.4%
+79.56% a year
Each share's claim on the business
−94.6%
shrank without buying or selling a share
Diluted shares, split-adjusted
5.4M54.8M104.2M2020: 5.5M shares'202021: 37.0M shares'212022: 65.5M shares'222023: 79.8M shares'232024: 93.2M shares'242025: 103.2M shares'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years100% Under 1 year0%
Quarterly turnover
50.0%
of institutional shares changed hands
Top 10 managers, median time held
2.8 years

Super Investors

Investment managers reporting Day One Biopharmaceuticals, Inc. on Form 13F
B
BlackRock, Inc.
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
GC
Glazer Capital, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

4 more super investors behind a free account

See every manager holding Day One Biopharmaceuticals, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Day One Biopharmaceuticals, Inc. on Form N-PORT; together they hold 26.9% of the company
VT
Position value
$52.7M
% of company
2.38%
% of the fund
0.00%
As of
March 31, 2026
IR
iShares Trust
Position value
$41M
% of company
1.85%
% of the fund
0.06%
As of
March 31, 2026

23 more funds behind a free account

See every fund holding Day One Biopharmaceuticals, Inc. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support